Prescription drug · NDA
Heparin Sodium In Sodium Chloride NDC 51662-1578
Heparin sodium 10000 [USP'U]/100mL · Injection, Solution · Intravenous · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1578-1 | 51662157801 | 250 mL in 1 BAG (51662-1578-1)Marketed from Jul 15, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Heparin Sodium In Sodium Chloride
- Generic name (nonproprietary)
- heparin sodium in sodium chloride
- Active ingredients
- Heparin sodium — 10000 [USP'U]/100mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 017029
- Marketing start
- Listing expires
- Other FDA classes
- Heparin (Chemical structure)
- Identifiers
- Product ID 51662-1578_0ff8e2fb-b791-dd77-e063-6294a90ab4eaSPL ID 0ff8e2fb-b791-dd77-e063-6294a90ab4eaSPL set ID c72b193e-0687-e002-e053-2995a90a7182RxCUI 1658717UNII ZZ45AB24CA
- Pharmacologic class
- Anti-coagulant; Unfractionated Heparin
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451662157801followed by a unit qualifier and the quantityPackage 51662-1578-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Heparin sodium is indicated for: Prophylaxis and treatment of venous thromboembolism and pulmonary embolism; Atrial fibrillation with embolization; Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); Prevention of clotting in arterial and cardiac surgery; Prophylaxis and treatment of peripheral arterial embolism; Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 017029
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-276 |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Henry Schein, Inc. | 0404-9979 |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Cardinal Health 107, LLC | 55154-9585 |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Cardinal Health 107, LLC | 55154-9583 |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/.5mL | Injection, SolutionIntravenous, Subcutaneous | Cardinal Health 107, LLC | 55154-9589 |
| Heparin Sodium | Heparin sodium 20000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-915 |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-459 |
| Heparin Sodium | Heparin sodium 20000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-915 |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Phlow Corporation | 81565-203 |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/.5mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-118 |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/100mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-517 |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/100mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-523 |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/100mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-518 |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/100mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 63323-522 |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1409 |
| Heparin Sodium | Heparin sodium 10000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-542 |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-540 |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-540 |
| Heparin Sodium | Heparin sodium 1000 [USP'U]/mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-540 |
| Heparin Sodium | Heparin sodium 5000 [USP'U]/.5mL | Injection, SolutionIntravenous, Subcutaneous | Fresenius Kabi USA, LLC | 63323-543 |
Showing 20 of 27.